Diabetes technology

Accuracy of Continuous Glucose Monitoring in Hemodialysis Patients With Diabetes

Diabetes CarePublished Diagnostic accuracy study

Performance · Accuracy of CGM vs blood glucoseResult — go to the resultMean difference (Bland-Altman) ∼+15 mg/dL

Authors' conclusion

In hemodialysis patients with diabetes, although MARD values were higher than traditional optimal analytic performance thresholds, error grids showed nearly all CGM values were in clinically acceptable zones. Further studies are needed to determine whether CGM improves outcomes in hemodialysis patients.

Study context

Population
Hospitalized maintenance hemodialysis patients with diabetes, October 2020 to May 2021
Participants
31 patients
Comparison
Dexcom G6 continuous glucose monitoring (CGM) vs blood glucose
Outcome
Accuracy of CGM vs blood glucose
Methodological detailsprotocolized glucose measurements
  • Protocolized glucose measurements

Performance

As reported in the abstract

Mean difference (Bland-Altman)

∼+15 mg/dL

Pearson correlation, averaged CGM vs blood glucose
0.84
Spearman correlation, averaged CGM vs blood glucose
0.79
Agreement rate (%20/20), overall period
48.7%
Agreement rate (%20/20), hemodialysis periods
47.2%
Agreement rate (%20/20), nonhemodialysis periods
50.2%
Mean ARD (MARD) across all time periods
∼20%
Median ARD, overall period
19.4%
Median ARD, nonhemodialysis periods (slightly lower)
18.2%
Median ARD, hemodialysis periods
22.0%

Original publication

Accuracy of Continuous Glucose Monitoring in Hemodialysis Patients With Diabetes. Diabetes Care. Published 30 August 2024. doi:10.2337/dc24-0635

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.